First Eagle Investment Management’s Strata Critical Medical SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.4M Buy
2,419,114
+104,500
+5% +$569K 0.02% 209
2026
Q2
$12.2M Buy
2,314,614
+48,371
+2% +$254K 0.02% 222
2026
Q1
$9.47M Buy
2,266,243
+136,693
+6% +$658K 0.02% 192
2025
Q4
$10.2M Buy
2,129,550
+336,199
+19% +$1.63M 0.02% 171
2025
Q3
$9.07M Buy
1,793,351
+439,731
+32% +$1.94M 0.02% 178
2025
Q2
$5.46M Buy
1,353,620
+225,800
+20% +$735K 0.01% 246
2025
Q1
$3.08M Buy
1,127,820
+591,866
+110% +$2.12M 0.01% 303
2024
Q4
$2.28M Buy
+535,954
New +$2.04M 0.01% 321

Other funds holding SRTA

First Eagle Investment Management's SRTA Position: Q3 2026 in Review

First Eagle Investment Management increased its Strata Critical Medical (SRTA) stake by 4.5% in Q3 2026, buying an estimated $569K and bringing the position to 2,419,114 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #209.

First Eagle Investment Management first reported a position in SRTA in Q4 2024 and has held it in 8 quarters since. 166 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • First Eagle Investment Management held 2,419,114 shares of Strata Critical Medical worth $12.4M as of Q3 2026.
  • First Eagle Investment Management bought 104,500 Strata Critical Medical shares in Q3 2026, an estimated $569K.
  • Strata Critical Medical made up 0.02% of First Eagle Investment Management's portfolio in Q3 2026, its #209 holding.
  • First Eagle Investment Management first reported a position in Strata Critical Medical in Q4 2024 and has held it in 8 quarters since.
  • 166 funds tracked by Wall St. Rank held Strata Critical Medical as of Q3 2026.

Based on First Eagle Investment Management's 13F filing for Q3 2026, filed 10 Nov 2026.